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Abstract: While the cellular functions of the coenzyme thiamine (vitamin B1) diphosphate (ThDP) 
are well characterized, the triphosphorylated thiamine derivatives, thiamine triphosphate (ThTP) 
and adenosine thiamine triphosphate (AThTP), still represent an intriguing mystery. They are pre-
sent, generally in small amounts, in nearly all organisms, bacteria, fungi, plants, and animals. The 
synthesis of ThTP seems to require ATP synthase by a mechanism similar to ATP synthesis. In E. 
coli, ThTP is synthesized during amino acid starvation, while in plants, its synthesis is dependent 
on photosynthetic processes. In E. coli, ThTP synthesis probably requires oxidation of pyruvate and 
may play a role at the interface between energy and amino acid metabolism. In animal cells, no 
mechanism of regulation is known. Cytosolic ThTP levels are controlled by a highly specific cyto-
solic thiamine triphosphatase (ThTPase), coded by thtpa, and belonging to the ubiquitous family of 
the triphosphate tunnel metalloenzymes (TTMs). While members of this protein family are found 
in nearly all living organisms, where they bind organic and inorganic triphosphates, ThTPase activ-
ity seems to be restricted to animals. In mammals, THTPA is ubiquitously expressed with probable 
post-transcriptional regulation. Much less is known about the recently discovered AThTP. In E. coli, 
AThTP is synthesized by a high molecular weight protein complex from ThDP and ATP or ADP in 
response to energy stress. A better understanding of these two thiamine derivatives will require the 
use of transgenic models. 
Keywords: thiamine triphosphate; adenosine thiamine triphosphate; thiamine triphosphatase; ad-
enylate kinase; CYTH; triphosphate tunnel metalloenzymes; thiamine diphosphokinase; ATP syn-
thase; thiamine diphosphate; glutamate dehydrogenase 
 
1. Introduction 
Thiamine (vitamin B1) is the precursor for thiamine diphosphate (ThDP), an essential 
coenzyme for many enzymatic reactions in prokaryotes and eukaryotes [1–3] (Figure 1). 
In animals, the main ThDP-dependent enzymes are the E1 subunits of 2-oxoacid (in par-
ticular, pyruvate and oxoglutarate) dehydrogenase complexes and transketolase [4]. 
These enzymes are essential in oxidative glucose metabolism, explaining why thiamine 
deficiency leads to severe lesions in particular in tissues with a high oxidative metabolism, 
such as brain and heart [5]. Thiamine deficiency disorders are still very common, espe-
cially in developing countries, and often go unnoticed, resulting in fatal outcome [6–8]. It 
is beyond doubt that the vast majority of the observed symptoms are due to a decreased 
oxidative metabolism in the nervous system and the heart due to decreased ThDP coen-
zyme function. Nevertheless, already in the 1950s and 1960s, the idea of a non-coenzyme 
role of thiamine or some thiamine derivative took shape, probably as a consequence of 
two observations: 
1. Thiamine deficiency leads to selective brain lesions, the diencephalon being the most 
affected [9,10]; 
2. Thiamine was reported to be released during electrical nerve stimulation [11].  
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Considering the now known complexity of the mammalian brain, the first observa-
tion might not be so surprising, but it still remains to be explained. Concerning the second 
observation, a careful review of the literature suggests that many older observations must 
be taken with care, because of a lack of reliable analytical methods available in these days 
[12]. Nevertheless, the hypothesis of thiamine non-coenzyme roles continues to be ex-
plored in particular in relation to metabolic regulations [13,14]. Indeed, it is now well es-
tablished that besides ThDP, at least two triphosphorylated thiamine derivatives (Figure 
1), thiamine triphosphate (ThTP) and the newly discovered adenosine thiamine triphos-
phate (AThTP), exist in most prokaryotic and eukaryotic cells [15–17], where they might 
have physiological roles. Moreover, in mammals, ThTP is hydrolyzed by a very specific 
25-kDA thiamine triphosphatase (ThTPase, EC 3.6.1.28), coded by the gene thtpa. We will 
refer to this enzyme as THTPA and use the more general term ThTPase for the enzyme 
activity. 
The aim of the present review is to discuss new data obtained on ThTP, AThTP, and 
their metabolizing enzymatic complexes (Figure 1).  
 
Figure 1. Structural formulas of thiamine and its major derivatives. ThDP is synthesized from thia-
mine and ATP by thiamine pyrophosphokinase (1). Hydrolysis of ThDP by thiamine pyrophospha-
tases (2) yields ThMP, which in turn can be hydrolyzed to thiamine by thiamine monophosphatases 
(3). ThDP can be phosphorylated to ThTP by two mechanisms: mitochondrial ATP synthase (4) and 
cytosolic adenylate kinase (5). ThTP can be hydrolyzed to ThDP by a very specific cytosolic 25-kDa 
thiamine triphosphatase (THTPA) but also by other hydrolases (6). ThDP can also be converted to 
AThTP by a ThDP adenylyl transferase (7). AThTP can be hydrolyzed to ThDP and AMP by a pu-
tative AThTP hydrolase (8). Another adenylated thiamine derivative, adenosine thiamine diphos-
phate (AThDP), not represented here, has been shown to exist in prokaryotes and eukaryotes, but 
its mechanism of synthesis has not yet been demonstrated in vitro. Pi, inorganic phosphate; PPi, 
inorganic pyrophosphate; ∆p, proton gradient (adapted from [18]). 
2. Thiamine Triphosphate: Occurrence, Synthesis, Regulation, and Role 
2.1. Occurrence of ThTP in Living Organisms 
The first reports on the existence of ThTP date back to the 1950s in rat liver [19], 
baker’s yeast [20], rat brain [21], and bacteria [22]. Though the existence of ThTP in these 
tissues was later confirmed, quantitative aspects should be taken with care as reliable 
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methods for the determination of ThTP became available only in the 1980s with the advent 
of highly selective and sensitive HPLC methods (for a discussion of this point, see [16,23]). 
It is also possible that in some cases, ThTP was confounded with AThTP, discovered much 
later [17]. With state of the art methods, ThTP could be detected, often in highly variable 
amounts, in practically all animal tissues, plants, fungi, and bacteria [15].  
In animal tissues, ThTP is constitutionally present in very variable amounts, reflect-
ing tissue-specific balances between synthesis and hydrolysis. In the rat brain, the turno-
ver of ThTP is relatively low with a half-life of 1–2 h [24,25]. In 2010, we published a vast 
study on the occurrence of ThTP and AThTP in human biopsies [26]. ThTP was found in 
practically all tissues tested, including all major organs and systems, in the range of less 
than 1% to over 20% of total thiamine. ThTP levels were generally higher in human com-
pared to the corresponding rodent tissues, which is probably due to the less active 25-kDa 
ThTPase, an important regulator of ThTP levels in animals (see below). While in the brain, 
ThTP is mainly localized in mitochondria and mitochondria-rich fractions (synapto-
somes), in skeletal muscle and liver, it is mainly in the cytosolic fraction, most probably 
reflecting different mechanisms of synthesis (see Section 2.2) [25–27]. 
On the other hand, in E. coli, it has to be induced by a carbon source in amino acid-
deficient media and can rapidly reach up to 50% of total thiamine [28,29]. As ThTP syn-
thesis in E. coli only occurs in a medium devoid of amino acids, it was suggested that ThTP 
might be involved in a response to amino acid starvation [28]. 
In plants, ThTP is found mainly in the plastids and mitochondria of the shoots rather 
than the roots and peaks early during the light period and the authors suggest that it may 
signal ThDP sufficiency [29]. 
2.2. Two Different Mechanisms of Synthesis of ThTP: Adenylate Kinase and ATP Synthase 
Different mechanisms were put forth concerning the synthesis of ThTP, among which 
the most straightforward is the transfer of a phosphate group from ATP to ThDP accord-
ing to the reaction ThDP + ATP  ThTP + ADP catalyzed by a ThDP:ATP phosphotrans-
ferase [30] (for a review, see [16]). However, such a mechanism was never confirmed. 
It is important to emphasize that ThTP, like ATP and other nucleoside triphosphates, 
is an “energy-rich” compound with two phosphoanhydride bonds and a high phosphoryl 
transfer potential. Its synthesis thus requires a significant energy input. 
It has now been firmly established that ThTP may be formed by two different mech-
anisms. The first mechanism is the synthesis of ThTP by cytosolic adenylate kinase 1 (AK1, 
myokinase, EC 2.7.4.3) according to the reaction first reported by [28]: ThDP + ADP  
ThTP + AMP instead of the more canonical reaction 2 ADP  ATP + AMP. Hence, in 
mammalian liver and skeletal muscles, ThTP is essentially synthesized by cytosolic AK1, 
explaining why ThTP is mainly found in the cytosolic fraction in these tissues [26,31–33]. 
Bacterial AKs (for instance, E. coli AK shares several regions of high homology with 
AK1 [34]) are also able to synthesize ThTP according to the above reaction [35]. Hence, 
ThTP synthesis seems to be a rather general property of type 1 AKs. With recombinant 
enzymes, ThTP synthesis is over 106 times lower than ATP synthesis [35], but this might 
be enough to ensure a constitutional and cytosolic synthesis of ThTP. However, ThTP 
synthesis by AK1 is not the only mechanism as ThTP levels are hardly decreased in tissues 
of transgenic AK1 knockout mice [36]. 
The second mechanism of ThTP synthesis seems to be related to ATP synthase (EC 
7.1.2.2, FoF1-ATPase). Indeed, energized isolated rat brain mitochondria are able to syn-
thesize ThTP from ThDP and Pi, which can then be exported in exchange with Pi or nucle-
otides [32]. This synthesis is tightly coupled to the respiratory chain and depends on the 
existence of a transmembrane H+ gradient, suggesting that ThTP is synthesized by a mech-
anism similar to ATP and involving ATP synthase. Interestingly, only brain but not liver 
mitochondria were able to synthesize ThTP. This suggests a cell-specific regulation of 
ThTP by mitochondria. In E. coli, ThTP can accumulate to over 50% of total thiamine and 
is most probably synthesized by ATP synthase [37]. Very recently it was shown that in 
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Arabidopsis shoots, ThTP synthesis oscillates during the diel period and may accumulate 
during the early light period [29]. This synthesis occurs in the plastids and mitochondria, 
is dependent on the proton gradient, and is coupled to photosynthetic processes, again 
suggesting the involvement of chloroplast and mitochondrial ATP synthases. ThTP syn-
thesis has not yet been reported with purified and reconstituted ATP synthase, but the 
purified F1 fragment may hydrolyze ThTP at a very low rate [37]. 
2.3. Regulation of Intracellular ThTP Concentrations 
Mitochondria, E. coli and chloroplasts, are able to synthesize ThTP, strongly linking 
this synthesis to proton gradient-dependent energy processes. It is not established 
whether this synthesis is a mere side reaction of ATP synthase or a physiologically rele-
vant process. The fact that mitochondrial ThTP synthesis is tissue specific (brain mito-
chondria may synthesize ThTP, while liver mitochondria may not [32]) would suggest the 
latter. With this respect, it is also interesting to note that ThTP synthesis seems to be de-
creased in cardiovascular system biopsies of patients with heart failure syndrome [26]. 
Indeed, the ratio ([ThTP + [ThMP])/([Thiamine] + [ThMP]), which we called the “thiamine 
phosphorylation ratio”, was low (<1) in these patients, while it did not correlate with age 
or underlying neoplastic disease. As these patients suffer from metabolic shifts and de-
creased energy generating processes, this observation emphasizes the coupling of ThTP 
synthesis to cell energy metabolism. Indeed, ThTP steady-state concentrations are a bal-
ance between synthesis and hydrolysis [24,25]. In case of energy shortage, hydrolysis 
would prevail, leading to accumulation of ThMP (Figure 1). Intracellular ThDP concen-
trations are one or two orders of magnitude higher than those of ThTP and ThMP, so that 
no significant changes in ThDP levels are observed when ThTP is hydrolyzed but ThMP 
accumulates. 
An intriguing observation was that some tissues have an extremely high proportion 
of ThTP compared to total thiamine, sometimes exceeding 70%. This is the case for pig 
[33] and chicken [38] skeletal muscles and fish electric organs (which are ontogenetically 
derived from skeletal muscle) from Torpedo marmorata [39] and Electrophorus electricus [40], 
all tissues with high AK1 activity. Why these tissues specifically accumulate ThTP re-
mained a mystery until it was understood that, though AK1 is responsible for ThTP syn-
thesis in the tissues (but also in the skeletal muscle of other species), THTPA hydrolyzes 
ThTP in a highly efficient manner except in fish, birds, and pigs (Table 1). Indeed, fish 
have a specific THTPA, but its activity is orders of magnitude lower than that of the mam-
malian enzymes and no significant cytosolic ThTPase activity has ever been measured in 
fish tissue [15,41]. Birds have completely lost a region encompassing 30 genes including 
the gene coding for THTPA [41]. Due to several amino acid changes, the domestic pig 
expresses a catalytically inactive THTPA [42]. Hence, the accumulation of ThTP in skeletal 
muscle and electric organs is the consequence of high AK 1 activity combined with low or 
absent THTPA activity. These results emphasize the importance of THTPA in the regula-
tion of cytosolic ThTP concentrations. 
Rats, genetically selected for high-alcohol sensitivity, have higher ThTP levels in liver 
and brain compared with low-alcohol sensitivity animals [43], but the significance of this 
observation remains to be established. 
Based on expression analysis, a recent study suggested a correlation between the pi-
tuitary tumor-transforming gene family and ThTP metabolism [44], but obviously they 
confounded ThTP with thymidine triphosphate. 
2.4. The Special Case of ThTP Synthesis in E. coli 
For a long time, we have been looking for conditions that would alter intracellular 
ThTP concentrations in a simple system, such as cultured neuroblastoma cells; however, 
no reproducible conditions were found (unpublished results). We now know that in these 
cells, ThTP is synthesized constitutionally by AK and that THTPA is not expressed at the 
Biomolecules 2021, 11, 1645 5 of 20 
 
protein level in neuroblastoma cells in its active from, though the mRNA is present and 
ATP synthase does not play a significant role in ThTP synthesis in these cells [26]. 
Therefore, we looked for a simpler model, such as E. coli. Indeed, we found that in E. 
coli cells, ThTP is detected under very specific conditions: aerobic growth, amino acid star-
vation, and a suitable sugar or sugar-derived carbon-source [28,37], conditions recently 
confirmed by another group [29]. ThTP synthesis is inhibited by amino acids, with some 
(Cys, Glu, Arg, and Trp) being particularly effective, pointing to a metabolic regulation of 
ThTP synthesis. The requirement of a carbon source (different from amino acids) is ex-
plained by the necessity of generating a proton gradient. However, not all carbon sources 
that generate a proton gradient were equally efficient to significantly boost ThTP synthe-
sis. Indeed, the most efficient were those feeding into glycolysis (D-glucose, D-fructose, D-
gluconate, pyruvate, and L-lactate), while intermediates of the citric acid cycle (citrate, 
oxoglutarate, fumarate, malate, and oxaloacetate) were inefficient. Some (acetate, gluta-
mate, succinate) were of intermediate efficiency. 
This suggests that pyruvate oxidation is an essential condition for ThTP synthesis 
[37]. When pyruvate oxidation is blocked by fluoroacetate, which is transformed into flu-
orocitric acid, an inhibitor of aconitase [45], no ThTP synthesis occurs (Figure 2A). Py-
ruvate is required because it yields NADH, a substrate for the respiratory chain. The re-
quirement for oxygen was later recognized when it was found that ThTP is synthesized 
by ATP synthase, requiring an active respiratory chain [37]. However, it appears that py-
ruvate is also required because it yields an “activator” essential for ThTP synthesis. This 
activator is supposedly synthesized either during the early reactions of the Krebs cycle or 
after the branching point towards glutamate and glutamine (Figure 3). In order to test this 
hypothesis, we used an E. coli strain deleted in glutamine synthetase (Figure 2B). This 
strain was unable to accumulate ThDP, suggesting that glutamine, or a downstream me-
tabolite, might activate ThTP synthesis or the accumulation of a metabolite upstream of 
glutamine would inhibit ThTP synthesis. 
 
Figure 2. Importance of the pyruvate–glutamine axis for ThTP synthesis in E. coli. (A) Inhibition of 
ThTP synthesis by fluoroacetate (FA). E. coli cells from the BL21 strain were grown in LB medium 
and then transferred into a M9 minimal medium (devoid of amino acids) for 20 min (37 °C, 250 rpm) 
in the absence or the presence of either pyruvate (10 mM) or pyruvate (10 mM) + fluoroacetate (10 
mM) and ThTP was determined by HPLC [28]. (B) ThTP synthesis is strongly decreased in a strain 
specifically deficient in glutamine synthetase (JW3841-1 derived from parent strain MG1655/K12 
- ATCC 47076). Both strains were grown in minimal medium in the presence of 10 mM D-glucose 
for the indicated times and ThTP was determined as above. Single gene deleted strain JW3841-1 [46] 
(CGSC # 10775) was obtained from the Genetic Resource Center (Yale University, New Haven, CT, 
USA) (data are from [47] and expressed as mean ± SD). 
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These results again underscore the importance of a metabolic regulation of ThTP syn-
thesis in E. coli and possibly the existence of a regulatory switch located between pyruvate 
and oxoglutarate [37] (Figure 3). 
 
Figure 3. Mechanism of ThTP synthesis in E. coli and possible regulation. It seems that 
ThTP synthesis by a chemiosmotic process requires an activator synthesized either dur-
ing the early reactions of the Krebs cycle or after the branching point towards glutamate 
and glutamine. ThTP synthesis by AK is negligible in E. coli under these conditions. 
Note that E. coli isocitrate dehydrogenase requires NADP+ and not NAD+ as co-substrate 
[48] (PDH, pyruvate dehydrogenase; GDH, glutamate dehydrogenase; GS, glutamine 
synthetase). 
2.5. Possible Physiological Roles of ThTP in Nerve Tissue 
2.5.1. A Specific Role of ThTP in Nerve Excitability 
Historically, it was thought that ThTP might have a specific role in membrane excit-
ability and nerve conduction. This hypothesis was, among others, based on the following 
two observations: 
1. The existence of very high levels of ThTP in electric organs, rich in Na+ channels 
[39,40], but this is probably just a coincidence due to high AK1 and low THTPA ac-
tivity in these tissues as mentioned above.  
2. The electrical stimulation of isolated nerves leads to a release of thiamine, probably 
resulting from a dephosphorylation shift of higher thiamine phosphoester, such as 
ThDP and ThTP [11]. 
In agreement with the latter observation, we could show that intermittent light stim-
ulation of the photosensitive baboon Papio papio resulted in a decreased [ThTP]/[ThMP] 
ratio of the occipital (visual) cortex in the animals [49]. In view of what we now know 
about the synthesis of ThTP in nervous tissue, these results might just reflect a decreased 
synthesis of ThTP by ATP synthase under highly energy consuming conditions (see Sec-
tion 2.3). Under such conditions, hydrolysis of ThTP would continue, leading to decreased 
ThTP and increased ThMP levels. ATP shortage might also lead to decreased synthesis of 
ThDP by thiamine di(pyro)phospkokinase (TPK1) according to the reaction thiamine + 
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ATP  ThDP + AMP (EC 2.7.6.2), the only known enzyme involved in ThDP synthesis in 
animals. 
Hence, there is no strong evidence that ThTP may play a role in nerve excitability. 
2.5.2. ThTP and Neurotransmitter Release 
Several studies suggest an involvement of ThTP in neurotransmitter release. Hence, 
ThTP (> 0.1 mM), but also ThDP, induced a Ca2+-dependent dopamine release in the rat 
striatum [50]. This effect might be mediated by extracellular purinoceptors. An ancient 
study suggested a role of thiamine, and possibly ThTP, in cholinergic transmission in the 
electric organ of Torpedo marmorata [39]. This was based on the presence of very high con-
centrations of thiamine and its phosphate esters in the cytoplasm of the electric organ. 
2.5.3. ThTP and Protein Phosphorylation 
As pointed out above, ThTP, like ATP, has a high phosphate group transfer potential 
and could thus be a phosphate donor in protein phosphorylation reactions. This hypoth-
esis was tested using [γ-32P]-ThTP on membranes of the acetylcholine-rich electric organ 
of T. marmorata. In these preparations, ThTP indeed phosphorylated the protein rapsyn, 
associated with the nicotinic acetylcholine receptor and essential for the clustering of the 
receptors at the neuromuscular junction [51]. This phosphorylation occurred at low ThTP 
concentrations (5–25 µM) on histidine residues in the absence of added kinases. The phys-
iological relevance of this phosphorylation, however, remains to be attested. 
2.5.4. ThTP and Membrane Chloride Permeability 
ThTP was also thought to be directly involved in the regulation of ion channels in 
nerve cells [52]. When synaptoneurosomal membrane vesicles prepared from rat brain 
were incubated with thiamine or ThDP in order to increase intravesicular ThTP levels, the 
ThTP levels correlated with chloride membrane permeability [53–55]. In order to identify 
possible chloride channels involved in these permeability changes, we tested the addition 
of ThTP to excised inside-out patches in cultured mouse neuroblastoma cells. Under these 
conditions, ThTP at relatively low concentrations (<10 µM) activated very high conduct-
ance chloride channels of 300–400 pS, the so-called maxi chloride channel [56]. At this 
time, neither the identity nor the role of this channel was known. It now appears that its 
core component is the organic anion transporter SLCO2A1, which, in its resting (closed) 
state, functions as a prostaglandin transporter and in its active (open) state as a channel 
releasing mainly chloride and ATP [57]. This channel is thought to be involved in cell 
volume regulation and purinergic cell-to-cell signaling. 
2.5.5. ThTP and Glutamate Dehydrogenase 
ThTP (1 and 10 µM) allosterically activates commercial preparations of the purified 
glutamate dehydrogenase (GDH) from bovine liver [14], though no in vivo data are avail-
able. GDH is at the crossroads of carbon and nitrogen metabolism. Indeed, it is thought 
that in mammals, the reaction catalyzed by GDH is favored in the catabolic sense (synthe-
sis of 2-oxoglutarate from glutamate). 2-Oxoglutarate can be either catabolically decarbox-
ylated by 2-oxoglutarate dehydrogenase and continue through the citric cycle or anaboli-
cally funneled into amino acid metabolism by transamination. In microorganisms and 
possibly plants, GDH functions in the anabolic sense of glutamate synthesis from 2-ox-
oglutarate and NH4+ and may play a role in nitrogen assimilation [58]. Hence, the balance 
of these pathways is essential for the energy status of the cells in all organisms. 
3. Thiamine Triphosphatases 
No specific ThTPases have been identified in microorganisms, fungi, or plants, but a 
membrane-associated and a cytosolic ThTPase have been extensively studied in animal 
cells. In addition to these two ThTPases, myosin is able to hydrolyze ThTP to ThDP [59]. 
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ThTP may bind to a regulator site on myosin, but it does not seem to affect muscle con-
traction [60]. 
E. coli represents a particularly interesting case. In E. coli, ThTP accumulation is al-
ways transitional, with a maximum after 1 or 2 h. Thereafter, ThTP levels steadily decrease 
(Figure 2B, [28]). Decreased ThTP levels are concomitant with increased ThDP levels, sug-
gesting a mechanism of hydrolysis that starts to prevail over synthesis. No specific enzy-
matic mechanism of ThTP hydrolysis has been evidenced so far in E. coli. However, ThTP 
is hydrolyzed by the purified F1 subunit of E. coli ATP synthase with an apparent Km of 40 
µM but a very low kcat of 1.5 min-1 [37]. This result is not surprising if ATP synthase is 
responsible for ThTP synthesis, and one can expect that, as for ATP, ThTP is hydrolyzed 
by F1-hydrolyzing activity. 
3.1. Mammalian Membrane-Associated ThTPase 
A membrane-associated ThTPase is present ubiquitously in mammalian cells. It has 
not yet been identified at the molecular levels and it is not clear whether this enzymatic 
activity results from one or several enzymes and to what level it is physiologically rele-
vant. This enzyme retained some attention as thiamine was thought to have a role in nerve 
excitability, a hypothesis now more or less abandoned in favor of a more metabolic role 
[16,23]. 
This ThTPase activity was first reported in the rat brain [61], but it seems to exist in 
most mammalian tissues, where it is found in all particulate fractions. It is activated by 
both Mg2+ and Ca2+ and has a Km in the millimolar range for ThTP. It is competitively 
inhibited by low concentrations of ATP and ADP, with IC50 values of 20 µM for ATP and 
75 µM for ADP [62]. These results suggest that the active site has a much higher affinity 
for adenine nucleotides than for thiamine compounds. It remains possible that the enzyme 
would be a nucleoside triphosphatase with broad substrate specificity.  
A membrane-associated ThTPase with somewhat different properties was later de-
scribed in electric organs [40,63,64] and skeletal muscle [65]. It is not clear whether it is 
distinct from the brain enzyme or just an isoform with different properties. The distinctive 
feature of this ThTPase is its strong activation by chaotropic anions (I- > SCN− > NO3− > Br− 
> Cl−), a property not observed for the brain enzyme, which, on the contrary, is inhibited 
by anions. Though the enzyme could be solubilized by detergents, the activity was lost 
during purification [66]. 
Very recently, the solubilization and the partial purification of the chicken liver en-
zyme was reported [67]. The ThTPase activity was coeluted with ATP and ITP hydrolyz-
ing activities in a high molecular mass fraction and the Km for ThTP was about 2 mM. 
From what we presently know, it is likely that the membrane-associated ThTPase 
activities are not from genuine ThTPases but rather nucleoside triphosphatases with 
broad substrate specificity. 
A membrane-associated brain synaptosomal protein, binding thiamine phosphory-
lated derivates, including ThTP, seems to have ThTPase activity [68,69]. The authors re-
port a pH optimum of 7.4 and an apparent Km of 52 µM, which is somewhat lower than 
reported earlier for the membrane-associated ThTPase. It is not clear whether this protein 
is identical to the membrane-associated brain ThTPase mentioned above. 
3.2. Soluble 25-kDa ThTPase (THTPA) 
3.2.1. Characterization, Structure, and Evolution of THTPA  
A soluble ThTPase (THTPA) was first described in 1972 [70]. This enzyme proved to 
be more interesting than the membrane-associated enzyme. Though mainly cytosolic, one 
study suggested that a soluble ThTPase with somewhat different properties exists in the 
mitochondrial matrix and intermembrane space [71]. It is not clear whether it is the same 
or a different enzyme. 
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THTPA was purified to homogeneity by A. Makarchikov in 1992 from bovine brain 
[72]. This enzyme requires Mg2+ as cofactor, but it is inhibited by Ca2+, but its most inter-
esting property is its near absolute specificity for ThTP as substrate and a relatively low 
Km (43 µM), suggesting that it is a genuine ThTPase. The recombinant human ThTPase 
was cloned, produced in E. coli, purified, and sequenced in 2002 [73]. The human enzyme 
is composed of 230 amino acids, has a predicted molecular mass of 25.55 kDa, and is lo-
calized to chromosome 14q11.2. ThTPase activity and THTPA mRNA are widely distrib-
uted in mammalian tissues, with no apparent specificity for nervous tissue [73,74]. Shortly 
after the publication of the primary structure of THTPA, Iyer and Aravind detected the 
presence of a common motive between mammalian THTPA and the CyaB protein from 
Aeromonas hydrophila, a non-canonical adenylate cyclase [75]. More importantly, they 
showed that “the CyaB like adenylyl cyclase and the mammalian ThTPases define a novel 
superfamily of catalytic domains called the CYTH (contraction of CyaB and THTPA) do-
main that is present in all three superkingdoms of life”. The conserved CYTH motive is 
mainly formed by the sequence EXEXK (where X is any amino acid) characteristic of this 
family and is an ancient enzymatic domain, present in the Last Universal Common An-
cestor (LUCA) and involved in nucleotide or organic phosphate metabolism [75]. In 2006, 
Gong et al. noticed similarities between the crystal structure of Cet1 RNA triphosphatase 
(EC 3.1.3.33) from Saccharomyces cerevisiae and the structures of bacterial and archaeal 
CYTH proteins [76]. All these enzymes had an active site composed of an eight-strand ß-
barrel forming a topologically closed tunnel. They proposed that this tunnel fold was the 
prototype of a larger superfamily termed triphosphate tunnel metalloenzymes (TTMs), 
including the CYTH branch and able to bind triphosphorylated substrates, such as ATP 
and ThTP, and requiring divalent metal ions as activators. Some bacterial members of this 
family, such as the N. europaea (NeuTTM) and E. coli (YgiF), are functional inorganic tripol-
yphosphatases [77,78] and so are the A. thaliana ortholog AtTTM3 [79] and the Hippeastrum 
HpAC1 protein [80] (Figure 4). The latter was considered an adenylate cyclase until its 
enzymatic and structural characterization revealed predominant triphosphatase activity. 
Hence, the authors suggested renaming the protein HpPP1 or HpTTM1 [80]. In A. thaliana, 
two other TTMs, TTM1 and TTM2, are involved respectively in pathogen resistance and 
leaf senescence [81]. Surprisingly, both have a higher activity towards PPi than towards 
triphosphorylated substrates and both carry a uridine kinase domain in addition to the 
CYTH domain. The only archaeal TTM protein characterized enzymatically proved to be 
a tripolyphosphatase [82]. 
The picture that emerges is that TTM proteins evolved from an inorganic tripoly-
phosphatase acquiring new substrate specificities in fungi and some protists (RNA tri-
phosphatase) and animals (ThTPase) or even new catalytic mechanisms in some bacteria 
(CyaB like adenylyl cyclase) [83]. The recombinant form of the plant Brachypodium distach-
yon (BdTTM3) even shares high triphosphatase activity (binding both tripolyphosphate 
and ATP) and low adenylate cyclase activity and might be involved in the mechanism 
underlying responses to wounding stress [84]. 
Interestingly, all metazoans (from sea anemone to humans) possess one TTM protein 
with ThTPase activity. Birds are a notable exception: a whole region of 30 genes, including 
the thtpa gene, has disappeared on chromosome 14 [41], leaving this branch as the only 
one known without a TTM protein. Moreover, fish and pigs, though retaining their 
THTPA orthologs, have practically no activity [15,41,42], which is probably the reason 
why ThTP accumulates in these tissues (see Section 2.3 and Table 1). 
The mammalian enzyme is well conserved, with an estimated evolutionary period of 
4.4 million years, corresponding to an average rate of amino acid substitutions of 1.41 x 
10-9 per site per year [85]. The three-dimensional structure of mammalian THTPA was 
obtained by NMR [86] and crystallography [41], confirming an open tunnel structure of 
the active site, closed by substrate binding (Figure 5). Mass spectrometry and site-directed 
mutagenesis confirmed a high affinity (micromolar range) and high specificity for ThTP, 
probably due to the Trp-53 residue responsible for a stacking interaction with the thiazole 
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ring of ThTP [41]. On the other hand,Tyr-39 and Lys-65 are important residues for cataly-
sis forming a catalytic dyad [41]. 
 
Figure 4. Tentative phylogenetic tree of the TTM (CYTH) superfamily. Currently, five different en-
zyme activities have been identified for members of the CYTH superfamily: tripolyphosphatase in 
bacteria (C. thermocellum, N. europaea, E. coli), an Archaea (Sulfolobus acidocaldarius) and plants (A. 
thaliana and Hippeastrum hybrids), adenylyl cyclase (in A. hydrophila and Y. pestis), RNA triphospha-
tase (in fungi and some protozoans), and ThTPase (in most metazoans, including vertebrates except 
for birds). Lately, pyrophosphatase activity (PPase) was recognized in A. thaliana TTM1 and TTM2, 
proteins containing a TTM and a uridine kinase domain [87]. The plant B. distachyon (BdTTM3) 
shares high triphosphatase activity and low adenylyl cyclase activity [84]. We hypothesize that the 
original activity in the Last Universal Common Ancestor (LUCA) was the hydrolysis of low molec-
ular mass polyphosphates. 
Though, Mg2+ is required for catalytic activity, and Mg2+ tightly binds to ThTP, it 
seems that Mg2+ dissociates from ThTP and binds to a different site, probably including 
the two glutamate residues of the EXEXK CYTH motive [41]. 
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Figure 5. Three-dimensional structure of human THTPA in complex with inorganic tripolyphos-
phate (RCSB PDB ID 3TVL, https://www.rcsb.org) [41]. Image created using Mol * [88]. 
3.2.2. Possible Physiological Roles of THTPA and Regulation 
From the data mentioned above, the very high cytosolic concentrations of ThTP in 
animal tissues where THTPA is either absent (chicken skeletal muscle) or poorly active 
(pig skeletal muscle, E. electricus electric organ) suggest that THTPA is indeed involved in 
the regulation of cytosolic ThTP concentrations. This is further emphasized by its high 
specificity for ThTP as substrate. However, the physiological significance of this reaction 
remains obscure. 
THTPA is mainly expressed in adult tissues. In the rodent brain, using in situ hybrid-
ization and immunohistochemistry, the strongest staining was observed with both meth-
ods in hippocampal pyramidal neurons, as well as cerebellar granule cells and Purkinje 
cells [89]. Soluble ThTPase activity is low in cultured and embryonic cells [26], but as 
mRNA is abundant, we proposed that the expression of the protein may be controlled 
post-transcriptionally or by post-translational modification, possibly through the highly 
conserved 200-nucleotide 3′-untranslated mRNA region [74]. With this respect, it should 
be emphasized that thtpa expression may be controlled by genes (Ndrg-1, melanotransfer-
rin) involved in cancer cell models [90,91]. 
A recent study suggested that THTPA, among several other proteins, might serve as 
biomarkers for stratification of tumor subtypes in breast cancer [92]. 
We produced transgenic mice overexpressing bovine ThTPase in mice with the aim 
of making the animals devoid of ThTP. These mice indeed had about two-fold increased 
ThTPase activities, but ThTP levels were unchanged [16]. Indeed, mouse ThTPA is cata-
lytically highly efficient and ThTP levels are already very low. Moreover, we did not know 
at the time that, except for skeletal muscle, most of the ThTP is produced intramitochon-
drially by ATP synthase. These mice did not display any evident phenotypic specificities.  
Another possibility would be that cytosolic ThTP accumulation would be cytotoxic. 
This is, however, clearly not the case in pig and chicken skeletal muscle and electric or-
gans.  
Linster et al. suggested the interesting hypothesis that THTPA is involved in metab-
olite repair, i.e., the regeneration of the coenzyme ThDP from ThTP, formed as a byprod-
uct of other reactions, such as adenylate kinase or ATP synthase [93]. However, even when 
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THTPA activity is absent, ThTP, except for pig and chicken skeletal muscle and electric 
organs, remains low compared to ThDP [15,26,33,40]. 
Table 1. Relative ThTP content and AK1 and THTPA activities in various animal species. This 
table shows a correlation between, on the one hand, ThTP levels and, on the other hand, low 









(nmol g−1 ww) 
Fish 
E. electricus electric organ 
E. electricus brain 






n. d. 1 
n. d. 1 
n. d. 1 
3.9 ± 0.5 (87%) 1 
0.37 ± 0.05 (7.1%) 1 
45 ± 4 (38%) 2 
Birds 
Chicken skeletal muscle 
Chicken brain 





3.7 (71) 4 
0.92 (8.4%) 4 
Mammals 
Pig skeletal muscle 
Mouse skeletal muscle (wt) 
Mouse skeletal muscle (AK-/-) 
Mouse brain (wt) 
Mouse brain (AK-/-) 
 
1.03 + 0.15 3 
1.3 ± 0.2 3 
— 
0.16 ± 0.2 3 
0.02 ± 0.01 3  
 
12.5 ± 0.5 4,6 
42 3 
— 
280 ± 30 5 
— 
 
20 (64%) 4 
0.026 ± 0.006 (0.35%) 3 
0.026 ± 0.008 (0.36%) 3 
0.009 ± 0.003 (0.09%) 3 
0.014 ± 0.01 (0.14%) 3 
1 [40]; 2 [39]; 3 [36]; 4 [15]; 5 [74]; 6 This activity is probably the result of other ThTPases than THTPA. 
(—, not measured; n. d.; not detected; ww, wet weight). 
We tried to produce thtpa knockout mice [94]. KO mice were generated from embry-
onic stem cell clones obtained from the Knockout Mouse Project (KOMP) repository at UC 
Davis (www.komp.org). We could generate chimera derived from the stem cells and all 
were partly THTPA+/+ and partly THTPA+/−. However, none of the chimerae transmitted 
the mutation: 12 chimerae were generated and a total of 455 pups were obtained. We gen-
otyped all of them and, surprisingly, they were all wild type. This could mean either that 
thtpa is essential for the differentiation of functional spermatozoids or the introduction of 
the KOMP cassette led to the disruption of genes essential for spermatozoid differentia-
tion. A role of thtpa in sperm cells is supported by a very high expression of its mRNA in 
testis with the highest expression observed in poorly differentiated spermatogonia close 
to the basal lamina, while no signal was observed in spermatozoids [74]. 
4. Adenylated Thiamine Nucleotides 
4.1. Discovery, Chemical Synthesis, and Chemical Properties 
When working on the synthesis of ThTP in E. coli cells, we observed a new chroma-
tographic peak appearing under conditions of carbon starvation [28], hence essentially 
conditions opposite to those inducing the appearance of ThTP. Here, it must be empha-
sized that analysis of thiamine compounds relies on the precolumn derivatization to flu-
orescent thiochrome derivatives [95]. This new fluorescent peak was not observed in the 
absence of thiamine-specific precolumn derivatization and had fluorescence excitation 
and emission spectra compatible with a thiochrome derivative [96], suggesting that it 
might correspond to a new thiamine derivative. After purification and identification using 
a combination of mass spectrometry and NMR, it proved to be an adenylated thiamine 
derivative, which could be either considered as thiaminylated ATP or adenylated ThDP 
(Figure 1). While many adenylated B vitamins are known (i.e., NAD+, FAD, acetyl-CoA) 
and are considered to be remnants from an RNA world [97], this was the first adenylated 
thiamine compound ever to be identified. As this molecule exists in only very small con-
centrations (micromolar and submicromolar concentration range) as is the case for most 
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vitamins as well as its opposite regulation in E. coli compared with ThTP, we preferred 
the term adenosine thiamine triphosphate (AThTP) rather than thiaminylated ATP, so as 
to emphasize its role as a vitamin derivative. AThTP was shown to be present not only in 
E. coli (where it may account for up to 15% of total thiamine), but also in much smaller 
concentrations in animals, fungi, and the roots of A. thaliana plants [17,96,98]. The latter 
observation could however not be reproduced in another study [29]. 
Despite a relatively broad distribution, nothing is known about the regulation of the 
synthesis or hydrolysis of ThTP in eukaryotic cells and it cannot be excluded that AThTP 
is a waste product. 
AThTP could be chemically synthesized by condensation of ADP and ThDP cata-
lyzed by N,N’-dicyclohexylcarbodiimide [17,96] and identified by a combination of ESI 
tandem MS and 1H- 13C- 31P-NMR. More recently, improved methods of synthesis have 
been proposed [99,100]. 
During this synthesis, we observed the formation of another compound, which 
proved to be adenosine thiamine diphosphate (AThDP). This compound, could be de-
tected in small amounts in E. coli and mammalian liver, suggesting that it is a naturally 
occurring molecule [96]. 
Based on 1H-NMR and molecular modeling, we proposed that both AThTP and 
AThDP exist under a U-shaped folding, bringing together the adenine and thiamine moi-
eties [96]. In such structures, the C-2 proton of the thiazolium ring of thiamine, which is 
required for the catalytic activity of ThDP, is embedded in a hydrophobic environment 
formed by the adenine and aminopyrimidine rings, making it improbable that AThTP and 
AThDP are catalytically active. 
4.2. Regulation of AThTP Synthesis in E. coli 
As mentioned above, AThTP is synthesized in E. coli under conditions of carbon star-
vation, but a closer analysis revealed a much more complex situation [35]. 
1. It is not the absence of a carbon source per se that triggers AThTP synthesis, but the 
absence of its metabolization. Hence, AThTP accumulates in the presence of glucose 
when glycolysis is inhibited by iodoacetate, or in the presence of lactate when the 
respiratory chain is inhibited by KCN. 
2. AThTP synthesis probably requires a low molecular weight factor seemingly synthe-
sized from pyruvate. Indeed, uncouplers, such as CCCP, induce ThTP synthesis only 
in the presence of pyruvate or a pyruvate-yielding substrate (D-glucose or L-lactate). 
3. ThTP is an inhibitor of AThTP synthesis, explaining at least in part that both com-
pounds never accumulate together. 
Hence, AThTP may accumulate under two different conditions of severe energy 
stress: absence of an energy substrate (or inhibition of its metabolization) and uncoupled 
pyruvate oxidation. However, there is no obvious link with the stringent response to car-
bon starvation or catabolite repression [35]. 
4.3. AThTP Is Synthesized by a High Molecular Weight Complex in E. coli 
An AThTP synthesizing activity, according to the reaction ThDP + ATP (ADP)⇌ 
AThTP + PPi (Pi), was isolated from an E. coli supernatant after precipitation and Sephadex 
G-200 chromatography [101]. The enzyme activity was eluted in two nearly equal peaks 
of 355 and 190 kDa, the first probably a dimer of the second. This finding was confirmed 
more recently and both peaks contained multiple protein bands when analyzed by SDS-
PAGE [102]. 
The synthesis required ThDP and either ATP or ADP as substrates. A divalent cation, 
either Mn2+ or, the more physiological, Mg2+ was also required. The kinetics were complex, 
with a lag period and a sigmoidal behavior with respect to ADP (Hill coefficient = 2.1), in 
agreement with a multisubunit complex. Further purification systematically led to the loss 
Biomolecules 2021, 11, 1645 14 of 20 
 
of activity, possibly because of the dissociation of the complex. We tentatively called this 
enzyme complex a ThDP adenylyl transferase [101]. 
Another important point is that the enzyme is activated by a low molecular weight 
organic compound present in bacterial extracts [101]. This would be in agreement with 
the requirement of a metabolite of pyruvate oxidation in vivo (see Section 4.2).  
4.4. AThTP Hydrolysis in E. coli 
In contrast to ThTP accumulation, which is transient, AThTP accumulation is not: its 
levels remain high as long as the stress condition is present. However, addition of a carbon 
source to E. coli cells under carbon starvation will lead to the immediate disappearance of 
AThTP (Figure 6). The rapidity with which this disappearance occurs suggests the activa-
tion of an enzymatic mechanism of hydrolysis. An enzyme present in the bacterial mem-
brane extracts is able to hydrolyze AThTP to ThDP and AMP [17]. 
 
Figure 6. AThTP levels as a function of time in E. coli BL21 cells transferred to a minimal medium 
and incubated at 37 °C at 250 rpm in the absence of a carbon source. Aliquots were taken for deter-
mination of thiamine derivatives. The arrow indicates the addition of 10 mM D-glucose (mean ± SD, 
n = 3) (adapted from [103]). 
4.5. AThTP Hydrolysis in Animal Tissues 
In animal tissues, AThTP is hydrolyzed by a membrane-bound enzyme probably of 
microsomal origin [98]. In chicken and rat liver homogenates, this enzyme has a pH opti-
mum of 8.0 – 8.5, does not require Mg2+ as cofactor, and obeys Michaelis–Menten behavior 
with an apparent Km around 50 µM. The enzyme activity is highest in liver and kidney 
tissues. 
4.6. Physiological Roles of Adenylated Thiamine Derivatives 
Concerning the dephosphorylated compound AThDP, we only know that it is pre-
sent in minimal amounts in E. coli and mammalian liver and its possible role and metab-
olism are unknown. The fact that in mammalian tissues it is only detected in the liver, a 
metabolically highly active organ involved in many detoxification reactions, might sug-
gest that AThDP is a mere byproduct, possibly of the enzyme complex responsible for 
AThTP synthesis. 
The situation is different for AThTP. This compound accumulates in E. coli under 
very specific conditions of energy stress and may reach up to 15% of total thiamine. It is 
thus possible that it may act as some kind of alarmone.  
Recently, a very interesting hypothesis was suggested: AThTP might form 5′-thia-
mine-capped RNAs [90]. The authors were able to obtain short 5′-thiamine-capped RNAs 
with T7 RNA polymerase, but the existence of such caps in bacteria now needs to be 
proven. 
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It was reported that AThTP (10 µM) inhibits mammalian poly(ADP-ribose) polymer-
ase-1, an enzyme involved in various stress-related diseases, such as diabetes mellitus 
[104]. Molecular modeling of the binding of AThTP to poly(ADP-ribose) polymerase-1 
suggests a U-shaped conformation of the thiamine vitamer as suggested by 1H-NMR stud-
ies [96]. It is, however, not known whether such an interaction occurs in vivo. However, 
inhibition of poly(ADP-ribose) polymerase-1 by AThTP was not reproduced in a later 
study [99].  
Just like ThTP, AThTP activated purified GDH at µmolar concentrations [14]. 
5. Conclusions 
Sixty years after the discovery of ThTP, its physiological remains frustratingly elu-
sive. A specific role of ThTP in nerve excitability, as first claimed, could not be proven 
until now [16,23]. However, three major breakthroughs opened new gateways towards 
the understanding of its role. 
1. The first was the discovery that in E. coli, ThTP is induced under conditions of amino 
acid starvation in the presence of a carbon source, leading to the oxidation of pyruvate 
[28]. These results obtained from E. coli cells cannot necessarily be extrapolated to an-
imal cells. Indeed, there are no known conditions where animals reversibly accumu-
late ThTP (we do not consider here constitutive synthesis by adenylate kinase in skel-
etal muscle and electric organs due to inactive THTPA). 
2. The recognition that, in addition to being a byproduct of AK1, a reaction that is prob-
ably physiologically irrelevant, ThTP is synthesized by ATP synthase in E. coli, in 
mammalian mitochondria isolated from brain, and probably plants [29,32,37]. 
3. The molecular characterization of the soluble 25-kDa ThTPase and its extremely high 
specificity for ThTP as substrate [41,73]. 
These data do not favor a role of ThTP in membrane excitability but rather a meta-
bolic role. With this respect, it is intriguing that ThTP (and AThTP) activated purified 
glutamate dehydrogenase, a mitochondrial enzyme, at physiologically relevant concen-
trations of 1-10 µM [14]. Hence, the present data suggest that ThTP might play a role at 
the interface between pyruvate oxidation and amino acid metabolism (Figure 3). This is 
also in agreement with the observation that in E. coli, glutamine synthetase seems to be 
required for ThTP synthesis in vivo (Figure 2B).  
As for the other protagonist, THTPA, it is difficult to assume that an enzyme with 
such a high specificity for its substrate ThTP and such a high catalytic efficiency would 
have a role unrelated to ThTP hydrolysis. The possibility that THTPA is involved in the 
rescue of the coenzyme ThTP [93] remains a possibility, but it is not very likely as, in the 
brain for instance, ThTP is synthesized inside mitochondria. An intriguing point is the 
apparent post-transcriptional regulation of THTPA expression and increased expression 
of the protein in highly differentiated versus less differentiated cells [26,74,90] with the 
possible exception of spermatozoa [74]. It is probable that the production of a thtpa knock-
out mouse, provided transmitting chimera can be obtained, will yield precious infor-
mation concerning the possible physiological role of the ThTP/THTPA couple. 
Even more intriguing is the recent discovery of a second triphosphorylated thiamine 
compound, AThTP. In E. coli, AThTP is synthesized under conditions opposite to those 
leading to ThTP synthesis [17,103], i.e., carbon starvation, membrane potential collapse, 
suggesting a possible role in response to energy stress. 
In conclusion, it is hard to imagine that these high-energy compounds are just an 
accident of nature, in particular in E. coli, where they are synthesized under very specific 
and highly reproducible conditions of metabolic stress. Though such conditions have not 
yet been found in mammalian cells, they express a highly specific ThTPase involved in 
the regulation of cytosolic ThTP concentrations. Hence, thiamine triphosphorylated de-
rivatives still provide a challenging topic for future studies. In particular, the study of the 
regulation of ThTP and AThTP in E. coli might give interesting clues as to the possible 
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roles of these compounds. In animals, the successful production of thtpa knockout mice 
might be of interest. The identification of the AThTP synthesizing and hydrolyzing en-
zymes combined with transgenic animals might also constitute a promising approach. 
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Abbreviations  
AK1 Adenylate kinase 1 (myokinase) 
AThDP Adenosine thiamine diphosphate 
AThTP Adenosine thiamine triphosphate 
GDH Glutamate dehydrogenase 
GS Glutamine synthetase 
ThDP Thiamine diphosphate 
ThMP Thiamine monophosphate 
ThTP Thiamine triphosphate 
THTPA 25-kDa ThTPase 
ThTPase Thiamine triphosphatase 
TPK1 Thiamine diphosphokinase 1 
TTM Triphosphate Tunnel Metalloenzyme 
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